Subdivision of <scp>M1</scp> category and prognostic stage for de novo metastatic breast cancer to enhance prognostic prediction and guide the selection of locoregional therapy
Subdivision of the M1 and prognostic stage could serve as a supplement to the current staging guidelines for dnMBC and guide locoregional treatment.
Authors
- Fei Ma (ORCID: https://orcid.org/0000-0001-9432-1902)
- Min Xiao (ORCID: https://orcid.org/0000-0001-9421-6344)
- Lei Ji (ORCID: https://orcid.org/0000-0001-8391-9300)
- Xi Chen (ORCID: https://orcid.org/0000-0003-3855-2591)
- Qiao Li (ORCID: https://orcid.org/0000-0002-4547-1266)
- Qing Li (ORCID: https://orcid.org/0000-0003-2652-6070)
- Shanshan Chen (ORCID: https://orcid.org/0000-0001-9723-2403)
- Yang Luo (ORCID: https://orcid.org/0000-0002-5501-9935)
- Binghe Xu (ORCID: https://orcid.org/0000-0002-0234-2747)
- Pin Zhang (ORCID: https://orcid.org/0000-0001-8903-3666)
- Ying Fan (ORCID: https://orcid.org/0000-0003-3419-9399)
- Jiayu Wang (ORCID: https://orcid.org/0000-0002-5608-0738)
- Ge Song (ORCID: https://orcid.org/0000-0002-4730-5915)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2024-09-15
- DOI
- https://doi.org/10.1111/1759-7714.15452
- Citations
- 3
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 1.26